You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 4, April 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Genetics
 •Genetics, Other
 •Macular Degeneration
 •Alert me on articles by topic

Complement Factor H and Macular Degeneration

The Genome Yields an Important Clue

Arch Ophthalmol. 2006;124:577-578.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The Human Genome Project has provided investigators with important tools to dissect the molecular events that predispose to human disease. These tools include the human DNA sequence itself, the identification of novel genes within the sequence, and a catalog of human DNA sequence variation. Information obtained by the Human Genome Project played a critical role in 5 recent investigations that have identified complement factor H as an important susceptibility gene for age-related macular degeneration.1-5

Age-related macular degeneration (AMD) affects more than 10 million Americans and is the leading cause of blindness among the elderly. Age-related macular degeneration is a complex disease that results from interactions between genetic and environmental factors. Studies have shown that the risk of macular degeneration increases with older age, smoking, and excess dietary lipids.6 Significant genetic contributions have been demonstrated by increased concordance between identical twins, familial clustering, and increased risk to first-degree relatives.7 The characterization . . . [Full Text of this Article]


AUTHOR INFORMATION
Janey L. Wiggs, MD, PhD







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.